Search results
Results from the WOW.Com Content Network
50–250 mg 1x/1–4 weeks Xyosted: Auto-injector: 50–100 mg 1×/week Testosterone cypionate: Depo-Testosterone: Oil solution: 50–250 mg 1x/1–4 weeks Testosterone isobutyrate: Agovirin Depot: Aqueous suspension: 50–100 mg 1x/1–2 weeks Testosterone phenylacetate b: Perandren, Androject: Oil solution: 50–200 mg 1×/3–5 weeks Mixed ...
[33] [34] [35] Oral testosterone undecanoate is provided as 40 mg oil-filled capsules and requires administration 2 to 4 times per day (i.e., 80 to 160 mg/day) for substitution in men. [ 2 ] [ 33 ] [ 3 ] It must be taken with food containing at least a moderate or "normal" amount of fat in order to achieve adequate absorption.
Capsule: 40–80 mg 1x/1–2 days Methyltestosterone: Metandren, Estratest: Tablet: 0.5–10 mg/day Fluoxymesterone: Halotestin: Tablet: 1–2.5 mg 1x/1–2 days Normethandrone a: Ginecoside: Tablet: 5 mg/day Tibolone: Livial: Tablet: 1.25–2.5 mg/day Prasterone (DHEA) b – Tablet: 10–100 mg/day Sublingual: Methyltestosterone: Metandren ...
Capsule: 40–80 mg 1x/1–2 days Methyltestosterone: Metandren, Estratest: Tablet: 0.5–10 mg/day Fluoxymesterone: Halotestin: Tablet: 1–2.5 mg 1x/1–2 days Normethandrone a: Ginecoside: Tablet: 5 mg/day Tibolone: Livial: Tablet: 1.25–2.5 mg/day Prasterone (DHEA) b – Tablet: 10–100 mg/day Sublingual: Methyltestosterone: Metandren ...
Vial of Depo-Testosterone, a depot injection of testosterone. A depot injection, also known as a long-acting injectable (LAI), is a term for an injection formulation of a medication which releases slowly over time to permit less frequent administration of a medication.
10–50 mg 2–3×/week Testosterone enanthate: Delatestryl: Oil solution: 50–250 mg 1x/1–4 weeks Xyosted: Auto-injector: 50–100 mg 1×/week Testosterone cypionate: Depo-Testosterone: Oil solution: 50–250 mg 1x/1–4 weeks Testosterone isobutyrate: Agovirin Depot: Aqueous suspension: 50–100 mg 1x/1–2 weeks Testosterone phenylacetate b
In a phase III double-blind, randomized, controlled trial supported by Eli Lilly, nondiabetic adults with a body mass index of 30 or more, or 27 or more and at least one weight-related complication, excluding diabetes, were randomized to receive once-weekly, subcutaneous tirzepatide (5 mg, 10 mg, or 15 mg) or placebo. The mean percentage change ...
Lomustine is available in 5 mg (yellow capsule), 10 mg (white capsule), 40 mg (white & green capsule), and 100 mg (green capsule) gel capsules, referred to as Gleostine. [ 13 ] [ 8 ] Lomustine dosing is calculated based on body surface area.